Similar results were observed in the case of Jeko-1 and NCEB mantle cell lymphoma cells in which bortezomib alone clearly up-regulated MCL-1 expression, and this effect was attenuated by HHT (Fig. 3b). Here, MCL1 is linked to mantle cell lymphoma.